Lorenzo Barba retweeted
Our new paper out today on @NatureComms! We investigated brain-derived and big tau isoforms in #Alzheimer and #ALS and developed a new assay for brain-derived p-tau217.
Tau isoform mapping across tissues and biofluids reveals a signature distinguishing Alzheimer’s disease from amyotrophic lateral sclerosis idp.nature.com/authorize?res…
Lorenzo Barba retweeted
Check out our new study!
☑️p-tau 181 and 217 in blood are not as specific for AD as previously thought,
☑️they are also elevated in the blood of patients with ALS,
☑️IHC and MS analyses disclosed both p-tau species in muscle biopsies from ALS cases.
nature.com/articles/s41467-0…
Lorenzo Barba retweeted
Fantastic morning at the #DGN Kongress 2024 Berlin, discussing #SynapticHealth and synaptic biomarkers in blood, CSF, PET and pathology. Thanks to Markus Otto, Patrick Oeckl, Dietmar Thal @lorbarba and @M_Malpetti and the great audience @wbic_cam @DementiasUK
Lorenzo Barba retweeted
🚨Just published in @ESOstroke: Antithrombotic drugs for carotid artery dissection: Updated systematic review🚨
Weak evidence for #antiplatelets as standard for #carotidarterydissection. Treatment individualization is warranted!
Full article here: journals.sagepub.com/doi/10.…
Lorenzo Barba retweeted
Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial - The Lancet Neurology thelancet.com/journals/laneu…
Lorenzo Barba retweeted
When small vessel disease #SVD is mixed with #CAA signs, amyloid PET may help identify people at higher risk of cerebral bleeding 🩸🧠
Have a look at our study out in
@GreenJournal
@BenStorti
@NeuroBesta
@AUSLRomagna
@CAA_Disease
@ISA_AII_Young
neurology.org/doi/10.1212/WN…
Lorenzo Barba retweeted
Is left atrial appendage occlusion a valuable treatment option for patients with atrial fibrillation and #breakthroughstroke despite anticoagulation therapy? @davidseiffge @boersma_lucas ja.ma/47BEHMx
Lorenzo Barba retweeted
Barba et al. review the co-occurrence of Alzheimer's disease and Lewy body disease pathologies, and consider the diagnostic and prognostic value of neuroimaging and fluid biomarkers. tinyurl.com/mt5cxbuv
Lorenzo Barba retweeted
Barba et al. review the co-occurrence of Alzheimer's disease and Lewy body disease pathologies, and consider the diagnostic and prognostic value of neuroimaging and fluid biomarkers. tinyurl.com/mt5cxbuv
Lorenzo Barba retweeted
This fantastic study shows ALL even low levels of physical activity benefit the brain by reducing stroke risk. 🧠 🏃
👇
bit.ly/3IyFq5n
By
@RaffaeleOrnello
@s_rumeileh
@mattfos89
@fededs00
@MicheleRomoli
@luciodanna2
@Simona_Sacco_
@lorbarba et al
Lorenzo Barba retweeted
Curious about the feasibility of mechanical thrombectomy after ischemic stroke in the context of cardiac diseases? #AHAJournals #Review @luciodanna2 @s_rumeileh @giovmerl @mattfos89 @lorbarba @simona_sacco_ @NguyenThanhMD ahajrnls.org/3W0GjLI
Lorenzo Barba retweeted
This fantastic study shows ALL even low levels of physical activity benefit the brain by reducing stroke risk. 🧠 🏃
👇
bit.ly/3IyFq5n
By
@RaffaeleOrnello
@s_rumeileh
@mattfos89
@fededs00
@MicheleRomoli
@luciodanna2
@Simona_Sacco_
@lorbarba et al
Lorenzo Barba retweeted
ENRICH trial in @NEJM shows improved outcomes for lobar ICH treated with minimally invasive surgery. Surgery not effective for basal ganglia ICH. 30 day mortality lower with surgical rx. A major development in ICH rx options @WorldStrokeOrg @ESOstroke
nejm.org/doi/full/10.1056/NE…
Lorenzo Barba retweeted
We are VERY pleased to have published this paper showing that even low levels of physical activity reduce stroke risk. Absolutely fantastic paper which I believe will benefit and motivate many patients. Small changes can be real meaningful
"All levels of LTPA can be beneficial for stroke prevention. People should be encouraged to be physically active even at the lowest levels." Now online! jnnp.bmj.com/content/early/2… @RaffaeleOrnello , @Simona_Sacco_ , @mattfos89 ,@lorbarba , @s_rumeileh , @luciodanna2 ,@MicheleRomoli
Lorenzo Barba retweeted
If interested in molecular imaging biomarkers for early diagnosis and prognosis of early-stage dementias, see our updated systematic review of recent literature. #MCI #dementia #PET #Alzheimer #nuclearmedicine
See EJNMMI:rdcu.be/dyFyf link.springer.com/article/10…
Lorenzo Barba retweeted
🚨‼️Finally online our paper assessing outcome differences between LVO patients treated with EVT with AF detected before vs after the acute ischemic stroke ‼️🚨@SomaBanerjee73 @Simona_Sacco_ @StrokeImperial @Kyriako @s_rumeileh @MicheleRomoli @mattfos89
Lorenzo Barba retweeted
There’s a need to test AD 🩸 biomarkers in populations with comorbidities.
Sacubitril/valsartan, a heart failure drug (ARB+neprilysin inhib), will confound 🩸 Aβ tests reducing Aβ42/Aβ40 by ~30% (only ~10% ⬇️ in AD). No changes in p-tau, NfL and GFAP.
jamanetwork.com/journals/jam…
Sacubitril/valsartan and Alzheimer's disease biomarkers.
Great collaboration with @wagnersbrum demonstrating an important drug-test interaction with a commonly used AD blood test (Aβ42/Aβ40).
Also reassuring results in other biomarkers of neurodegeneration
jamanetwork.com/journals/jam…
Lorenzo Barba retweeted
Due medici italiani tra migliori ricercatori Università tedesca | ANSA.it ansa.it/emiliaromagna/notizi…
Lorenzo Barba retweeted
NCSE is a time-dependent neurological disease. Hyperperfusion on CTP may suggest #statusepilepticus and save time for treatment. Think about a pragmatic workflow!
Have a look at our paper out @JNNP_BMJ
Led by @ZiniAndrea @AUSLBologna
bit.ly/JNNP_CTPinNCSE
Lorenzo Barba retweeted
New paper 🚨@JAMANeuro. Blood neurofilament light chain (NfL) levels are elevated preceding clinical diagnosis of progression in #MultipleSclerosis. Great international collaboration @UCSF @ucsfhealth and @RC2NB @DKFBasel @UniBasel_en @JensKuhle 🧵
jamanetwork.com/journals/jam…






























